Conventional therapy in congestive cardiomyopathy has failed to change the final outcome of the disease (Goodwin and Oakley, I972) . It was recently stated (Goodwin, I974) that, 'at the present time the prognosis for severe congestive cardiomyopathy is so bleak and treatment so unsatisfactory that cardiac transplantation may be considered in desperate cases'. Despite reduction in heart size with bed rest, which is also seen in normal people who are immobilized (Saltin et al., I968) , relapse has occurred in many cases after mobilization. The rate of thromboembolic complications has been high (McDonald, Burch, and Walsh, I972) . Several other disadvantages may be expected from prolonged bed rest (Deitrick, Whedon, and Shorr, I948) .
In a recent study immediate relief from ischaemic chest pain was reported when the cardioselective beta-adrenergic receptor agent practolol was given to patients with acute myocardial infarction. The drug was well tolerated though some of these patients had signs of latent left-sided heart failure (Waagstein, Hjalmarson and Wasir, I974) . In some patients with acute myocardial infarction, acute congestive heart failure, and supraventricular tachy-Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy 1023 blood pressure and heart rate. On the basis of these findings it was considered that patients with congestive heart failure from other causes might also respond well to a reduction of tachycardia by betaadrenergic receptor blockade.
In the present study adrenergic beta-blocking agents were, therefore, given to patients with congestive cardiomyopathy of unknown origin, with long-standing signs of cardiac failure and a resting heart rate of about IOO beats/min. The effect of the treatment with beta-adrenergic blockade on their clinical condition, physical working capacity, and heart function, as judged from noninvasive techniques, forms the basis of this report.
Subjects
Seven patients, 3 men and 4 women, 33 to 59 years of age (47.5 + II.9) with a history of heart disease ranging from 6 months to 6 years (2.6+2.2) were studied (Fig. I) . The patients were chosen on the basis of a diagnosis of cardiomyopathy with congestive heart failure and an increased heart rate at rest. Their heart rates were 85 to II5 (98 ± I3) beats/min. The diagnosis of congestive cardiomyopathy was based on the criteria given by Goodwin and Oakley (1972) . Patients with overt coronary heart disease, congenital heart disease, acquired valvular disease, and hypertensive heart disease were excluded. Coronary angiograms were obtained in 2 patients (Cases I and 6) and were normal.
All patients were in a steady state or were deteriorating progressively at the start of therapy with the betaadrenergic receptor blocking agents. None of the patients had suffered during three months before the start of betablockade from any acute episode of disease indicating acute myocarditis, acute coronary heart disease, or acute embolism, for example.
The patients were on oral treatment with digitalis (digoxin) and diuretics (frusemide, spironolactone) for congestive heart failure, except for one (Case 7) who received only digitalis. Two patients (Cases 2 and 6) had been given parenteral injections of ethacrynic acid or frusemide in addition. The treatment with digitalis and diuretics was unaltered or reduced during the time that practolol was given. The clinical data are given in the case reports below and in Fig. i and Table I. Representative case reports Case I A 59-year-old woman had septicaemia at the age of 25. No sign of heart disease was seen at that time. In I962 a routine medical examination revealed third and fourth heart sounds but electrocardiogram and x-ray of the heart were normal. The patient had no cardiac symptoms except for infrequent ectopic beats. In April I968 heart failure developed rapidly over a period of a few weeks, culminating in pulmonary oedema. No clinical evidence of infection was present. Erythrocyte sedimentation rate, white blood cells, temperature, and virus titres taken on two occasions, were normal. Electrocardiogram showed left ventricular hypertrophy but the heart volume derived from the x-ray was 8oo ml or 410 ml per M2n. The patient improved on digitalis and diuretics. Left ventricular catheterization revealed a left ventricular end-diastolic pressure of I9 mmHg (2.5 kPa). Selective coronary angiogram was normal. The patient continued to have effort dyspnoea and was graded in functional group II until April I972 when her symptoms grew worse, with increasing dyspnoea and peripheral oedema. From August 1972 the patient shifted between functional groups III and IV. During 6 months the patient was admitted to hospital on 4 occasions for a total of 24 months. Chest x-ray showed a pronounced increase in heart size (see Table 4 and Fig. 7) , and right heart catheterization showed an increase in the mean pulmonary arterial pressure. Loud diastolic extra sounds, shortened left ventricular ejection time, and highly pathological apex cardiogram and echocardiogram were also recorded (see Tables 5 to 8 and Fig. 2) . In January I973, atrial fibrillation occurred which was easily converted by DC shock. The patient was given Slow deterioration occurred until December 197I when he was in functional group III-IV. From that time he was admitted to hospital 9 times for a total of 2j months until treatment with the beta-blocker was started. During the short periods at home he suffered from severe nocturnal dyspnoea and he had to sleep in the sitting position. In addition, since I969, the patient had short attacks of fainting related to exercise of moderate intensity. The frequency of the attacks was still increasing. Observation with telemetry and tape recording of electrocardiogram failed to reveal episodes of bradyarrhythmia or ventricular tachyarrhythmia. Electrocardiogram was normal and no effect was seen after therapeutic trials with different anticonvulsants. The attacks were, therefore, interpreted as being caused by inadequate cardiac output during exercise. In February 1973 treatment with practolol was started, resulting in improvement and disappearance of the nocturnal dyspnoea within a few days. It was then possible to withdraw spironolactone and the intermittent injections of frusemide. The resting heart rate was reduced (see Table 2 ) and an improvement in working performance was seen (see Table 3 ). The episodes of fainting were then infrequent. In March I974 he underwent an operation for a perforated appendix. The postoperative period was complicated by wound infection but he was nevertheless in good cardiopulmonary condition. Noninvasive investigation including echocardiography, which was group.bmj.com on June 25, 2017 -Published by http://heart.bmj.com/ Downloaded from Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy 1025 only performed after chronic beta-blockade, showed signs of general cardiomyopathy and no sign of outflow obstruction. A clear reduction of heart size was seen (see Table 4 ). Attempts to withdraw the beta-blocking agent were followed by immediate relapse of noctunmal dyspnoea and more frequent attacks of fainting. Table 7 and Fig. 3 ) and enlarged left ventricular diameter (see Table 8 ) and small stroke volume (see Table 6 ). This was confirmed by left and right heart catheterization and increased heart size in x-ray (see Table 4 ). After administration of practolol there was no immediate effect, but after about one month improvement was seen which was still in progress three months later. Initially the arterial hypotension and dizziness in the upright position previously seen were somewhat accentuated. After 2 months these symptoms had completely disappeared. The (-3db ) and a time constant of i.8-4.6 S (depending on the amplification). The left ventricular ejection time was measured from the carotid pulse and corrected for the heart rate according to Meiners (Meiners, 1958; Hartman, I964; Willems and Kesteloot, x967) . This correction expresses left ventricular ejection time as a percentage of the normal for the heart rate concerned. The apex cardiogram was recorded with 1 These data will be published in a future communication.
the patient in the left lateral position. The a wave was expressed as a percentage of the total amplitude of the pulse curve (H). Analogous to this conventional a/H ratio, the rapid filling wave (RFW) was also expressed as the RFW/H ratio, since most changes were seen in the early diastolic part of the apex cardiogram because of the very disturbed left ventricular function of the patients in this study. All measurements were calculated as the mean of at least 3 cardiac cycles.
Echocardiography: a commercially available ultrasonoscope (Ekoline 20, Mark II, Smith-Kline) was employed, using a 2.25 MHz transducer, with I0 cm focus and with a repetition rate of Iooo impulses/s. Polaroid photographs of the time-motion echo display were taken from a slave storage oscilloscope (Tektronix 603). The standard technique (Feigenbaum, 1972) of examining the mitral and aortic valves and the size of the left atrium and left ventricle was followed. Much care and time were taken to get the anteroposterior diameter of the left ventricle just below the aortic root and through or very close to both the anterior and posterior mitral leaflets. In order to standardize the measurement of the left atrium the beam had to go through and visualize the aortic leaflets as well. The stroke volume was calculated from the end-diastolic and end-systolic volumes derived by the cube method (Pombo, Troy, and Russell, I97I) and the ejection fraction from the stroke volume and end-diastolic volume. The mean rate of circumferential fibre shortening (mean VcF) was calculated according to , with the exception that left ventricular ejection time in the formula was derived from the carotid pulse curve.
Results
Adrenergic beta-receptor blocking agents were given for 2 to I2 months (Fig. i) to the 7 patients (Table i) . One patient was given alprenolol in a dose of 50 mg twice daily and the other 6 patients were given practolol in a dose of 50 to 400 mg twice daily. Before the treatment with beta-blocking agents these patients had severe manifestations of congestive cardiomyopathy as described in the case reports above. Four patients experienced an immediate reduction of dyspnoea and retrosternal oppression. The 3 remaining patients reported a gradual improvement starting after one month of treatment. Two patients with peripheral oedema and ascites, which had been resistant to large doses of diuretics, had a diuresis after the beta-blockade and were maintained free of oedema with lower doses of diuretics or none at all (see Table 9 ). In 3 patients (Cases I, 2, and 4) the improvement was considerable and a clear improvement was seen in Cases 5 to 7, whereas the changes were less in Case 3, but even this patient reported improved exercise performance. The patients generally complained of muscle tiredness at the beginning of beta-blockade, even at a low degree of physical exercise, and Meiners (1958) and expressed as a percentage of normal. X-ray of the heart A significant reduction of heart size as judged from chest x-ray was seen in 3 (Cases I, 2, and 4) out of the 6 cases with enlarged hearts (Table 4) . Some reduction occurred in Case 3. In 2 cases the heart size was unaltered.
Phonocardiogram
The amplitude of the pulmonary component of the second heart sound and of the diastolic extra sounds was judged according to a subjective 5-degree scale (Table 5) . A fourth heart sound and pulmonary component of degree 4 to 5 were considered pathological. Since clear-cut third heart sounds are always pathological in this age group, even degree 3 was considered abnormal. Because of poor clinical condition, Case 2 was not investigated before the start of beta-blockade. Case 3 had an enormously dilated left ventricle and weak and diffuse heart sounds. The other 5 patients had moderate to strong third heart sounds, which in Cases i, 4, and 7 disappeared after beta-blockade (Fig. 2-4 Table 8 ). The murmur disappeared in Case 4 (Fig. 3) (Table  6) , and in 2 of these it was extremely low (Cases 4 and 6). After chronic beta-blockade the left ventricular ejection time was considerably longer in Cases 4 and 6, with lesser increases in the others; no patient showed shortening of the ejection time. Fig. 2-4 ). Both rapid filling waves and the a waves were expressed as a percentage of the total amplitude of the curve (H). After treatment there was a decrease in the rapid filling wave/H ratio in all patients except Case 3 and a decrease of the a waves in 2 of them. Fig. 2-4 show the apex cardiograms of Cases I, 4, and 7 with complete return to normal after beta-blockade. No changes were seen in Case 3.
Echocardiography
The left ventricular end-diastolic diameter was very large (6.2 to 8.4 cm) in 4 cases and slightly enlarged in Cases 6 and 7 (Table 8 and Fig. 5 ). It was not measured initially in Case 2. Only a range could be given in Case i before beta-blockade because ofpoor definition of the endocardium. After beta-blocker treatment this dimension decreased in Cases i, 6, and 7. There was no change in the other 3 cases. The anteroposterior dimension of the left atrium was enlarged in 3 cases, close to the upper normal limit in 2 cases, and normal in Case 7. After betablockade the left atrium decreased in Cases i and 4 (cf. the changes of the apex cardiogram of these cases, Fig. 2 and 3) , probably increased slightly in Case 3, and was unchanged in the others. Since there were abnormal septal movements and therefore asymmetrical contractions of the left ventricle caused by conduction disturbances (Table i) or gross tricuspid regurgitation (Case 6), the ejection fraction could only be calculated in 2 cases before treatment, and it increased after beta-blockade in both of them.
The mean rate of circumferential shortening (mean VCF) was calculated in 5 cases before treatment. This rate increased in all except Case 3. Note that all cases, except Case 7, even after betablockade, had depressed left ventricular function as judged from the mean VCF and the ejection fraction. Case 2, who was only investigated after betablockade, had highly abnormal dimensions and a very low ejection fraction. The dominant clinical disturbance in Case 6 was tricuspid regurgitation, which decreased clinically after beta-blockade The dimension of the right ventricle decreased (Fig. 5) .
The jugular and hepatic pulse tracings showed less evidence of tricuspid regurgitation.
Vectorcardiogram
Vectorcardiographic signs of left ventricular hypertrophy were seen in Cases I, 4, and 7. In the other 4 patients there were conduction disturbances which made this diagnosis impossible (Table i ). In Cases 4 and 7 new vectorcardiograms were recorded after about 3 months on beta-blockade and showed no significant changes in Case 7 and a small but significant decrease in horizontal maximum vector from 2.8 mV to 2.3 mV in Case 4. In Case i, however, there was a much longer observation period, with I2 months on beta-blockade. This patient showed a remarkable change of the vector loops, with a decrease of the horizontal maximum vector from 2.0 to I.3 mV (Fig. 6 ).
Discussion
Chronic treatment with beta-adrenergic receptor blocking agents in 7 patients with congestive cardiomyopathy over periods ranging from 2 to I2 months blockers showing obvious decrease in heart size.
group.bmj.com on June 25, 2017 -Published by http://heart.bmj.com/ Downloaded from Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy 1033 resulted in an improved clinical condition with less exertional dyspnoea and retrosternal oppression, allowing the patients increased physical activity. This was reflected in higher physical working capacities at the exercise test. The findings from the noninvasive investigations indicate that heart function was improved during chronic betablockade. In some patients a pronounced reduction in heart size was found during this treatment. In all 7 cases in this study, the relative left ventricular ejection time increased, indicating an increased stroke volume. The AV02-difference was studied during exercise in 2 cases and no change was seen in one patient and a reduction from a very high value was seen in the other patient. The improved working capacity in these patients therefore could not have resulted from an increased AV02-difference; it was reached with a lower maximum heart rate and is likely, therefore, to have been attained by higher stroke volumes. This was confirmed in one patient (Case 4) in whom the stroke volume was investigated during maximal exercise using an invasive technique (to be published).
The diagnosis of congestive cardiomyopathy was made according to the criteria of Goodwin and Oakley (I972) who defined the disease as a diffuse primary myocardial disease of unknown origin with a depressed systolic function of the ventricles. Hypertrophic cardiomyopathy has been excluded, as echocardiograms and phonocardiograms showed no signs of outflow tract obstruction or of interventricular septal hypertrophy (Feigenbaum, 1972; Abbasi et al., I972) . Suspected metabolic disorders were excluded by normal levels of urine catecholamines and normal thyroid function tests. A collagen disease was not likely in these patients since the erythrocyte sedimentation rate and the titre of the antinuclear factor were within normal limits. Biopsies from buccal or rectal mucosa showed normal histology. Coronary heart disease was completely excluded only in two patients (Cases i and 6), two woman with no history of chest pain and with normal coronary angiograms. Coronary arterial disease cannot be absolutely excluded in the other cases, but all presented the clinical and haemodynamic features of left ventricular failure as in congestive cardiomyopathy. In 2 (Cases 3 and 5) retrosternal oppression on exercise was present, which disappeared after beta-blockade; angina-like chest pain has been reported in io per cent of cases with congestive cardiomyopathy despite normal coronary angiograms (Gau et al., 1970) . These authors noticed that a QS pattern could also be seen in patients with congestive cardiomyopathy and normal coronary angiograms. In one patient (Case 6) pressure tracings from both ventricles (to be published) and the form of the apex cardiogram suggested constriction. This was thought to be of myocardial origin. The heart was greatly dilated and additional pericardial constriction was excluded by angiocardiography.
The genesis of congestive cardiomyopathy is generally accepted to be of multifactorial origin but the causes operative in individual cases are rarely identifiable. In 6 of our cases the onset of symptoms occurred shortly after what might have been a virus infection. It is important to stress that none had any signs of infection during the last 3 months before the start of treatment with beta-blockade. Furthermore, the onset of symptoms occurred 6 months to 6 years (average 2.6 years) before the start of beta-blockade. One patient (Case 6), who already had some clinical findings indicating heart disease (enlargement of the heart but no subjective signs), suffered serious progression of her heart disease during the third trimester of pregnancy, shortly after a severe common cold. Intermittent infection may unmask a latent disease or aggravate a pre-existing one.
The management of congestive cardiomyopathy has not changed much during the past decade except for the use of pacemakers in bradyarrhythmias, lignocaine and DC shock in ventricular tachyarrhythmias, and frusemide and spironolactone in the treatment of oedema. The progression of the disease has, however, never been reported to be changed by this therapy, and death often results from a final ventricular arrhythmia. The regimen of prolonged bed rest advocated by McDonald and co-workers (I972) is difficult to administer when permanent improvement cannot be guaranteed. However, a reduction of sympathetic activity during prolonged bed rest comparable to the beta-blockade in this study could possibly explain a reduction in heart size seen in the study of McDonald and co-workers (I972). To use beta-receptor blocking agents in congestive cardiomyopathy seems paradoxical since the heart might be dependent upon raised sympathetic activity. However, reduction of a high heart rate might reduce the energy demand of the myocardium (Braunwald, I97I) and allow better diastolic filling and thus increase the stroke volume, thereby improving the efficiency of the heart and possibly allowing more energy to be used for the contractile work.
In the present study only patients with a steady progression of the disease have been included. The patients had been given conventional treatment with digitalis and diuretics for several weeks in hospital without significant benefit before the start of treatment with beta-blockers. The digitalis and diuretics were somewhat reduced after a time on beta-blockers and in some cases even stopped ( Weissler, Peeler, and Roehil, I96I; Fabian et al., 1972) . All patients in this study had several noninvasive findings typical of the last group. If the pump function of the left ventricle improves, these changes can be expected to be reversed. This was seen after beta-blockade, the most pronounced changes being a normalization of the pulmonary components and of the rapid filling waves, and disappearance of the pathological third heart sounds. The changes of the apex curves and diastolic extra sounds shown in Fig. 2 to 4 are remarkable. Such a dramatic return to normal tracings has not been seen in non-surgical cases in spite of experience of more than 5000 non-invasive investigations in our laboratory (Wallentin, unpublished observations).
Echocardiography has been shown to give much better estimation of the left atrial size compared to chest x-ray when angiography was used as a standard (Hirata et al., I969) . In a study at this hospital it has been found that the echocardiographic anteroposterior dimension of the left atrium is larger in many cases of myocardial infarction and hypertension than in normal individuals of the same age (Wikstrand and Wallentin, to be published). It is, also our experience that echocardiography demonstrates that the left atrium is enlarged in cases of severe aortic valvular disease, especially in relation to left ventricular failure, and in many of these cases this dimension decreases again after surgery. Two of our cases with very obvious clinical improvement (Cases I and 4, Fig. 2 and 3 ) also showed a clear decrease of left atrial size echocardiographically.
Since the lower limit of mean VCF is about I circf/s (Paraskos et al., I97I; Cooper et al., I972) 4 out of 5 cases had unusually low values, depressed to 50 to 6o per cent of this lower limit. In spite of an increase in left ventricular ejection time after beta-blockade, which per se decreases mean VCF, an increase in mean VCF was seen in all patients except one (Case 3) who was unchanged in all noninvasive parameters except the left ventricular ejection time.
Reduction of vectorcardiographic signs of left ventricular hypertrophy in Cases i and 4 suggest reversal of the process of hypertrophy during treatment with beta-blocking agents. At least in Case 4, with unchanged left ventricular end-diastolic diameter, the vectorcardiographic findings could not be influenced by reduction of the heart volume.
It is suggested that the hypertrophy in congestive cardiomyopathy is not just a secondary compensatory change in a failing heart. Animal experiments have shown that administration of catecholamines will increase the rate of heart protein synthesis and thus induce hypertrophy without preceding decompensation (Kallfelt, Hjalmarson and Isaksson, to be published). Great efforts have been made in an attempt to develop experimental models of cardiomyopathy. Bajusz and co-workers (I969) have shown that the natural course of the disease in Syrian hamsters with hereditary cardiomyopathy could be accelerated by digitalis and catecholamines when given early in life in a vulnerable phase, and that treatment with beta-blocking agents could inhibit the effect ofcatecholamines. Jasmin and Bajusz (I973) have shown that verapamil, which has calcium antagonistic properties in the heart cell, could prevent the development of pathological changes in the myocardium of these Syrian hamsters. It might, therefore, be questioned whether high sympathetic tone in humans with cardiomyopathy also will induce an increased rate of protein synthesis, hypertrophy, necrosis, and deterioration of heart fimction, as found in the animal experiments.
In the present study one patient with severe congestive heart failure (Case I) was treated with the beta-i-and beta-2-receptor blocking agent alprenolol for I2 
